Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prolia vs Fosamax for Glucocorticoid-Induced Osteoporosis
NCT03005678Phase 4Completed
- Sponsor
- Tuen Mun Hospital
- Start
- Apr 2017
- Primary completion
- Nov 2019
- Modality
- Engineered Antibody Formats, Antibody Conjugates, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 4 trial of denosumab in glucocorticoid-induced osteoporosis (GIOP), sponsored by Tuen Mun Hospital. Started Apr 2017; status: completed.
02
Drugs
denosumab
03
Conditions
glucocorticoid-induced osteoporosis (GIOP)
Beyond the preview
Go deeper on NCT03005678.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03005678.